515(top 0.1%)
PR articles
52.9K(top 0.1%)
PR citations
107(top 0.1%)
PR h-index
119(top 0.1%)
h-index
605
documents
68.5K
doc citations
5.4K
citing journals
100
times ranked

Publications

541 peer-reviewed articles • 58,671 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Association of cognitive and structural correlates of brain aging and incident epilepsy. The Framingham Heart Study
Epilepsia, 2025, 66, 160-169
4.46Citations (PDF)
2Ultra-processed food consumption and risk of dementia and Alzheimer's disease: The Framingham Heart Study3.319Citations (PDF)
3Neuropsychiatry of atrial fibrillation: dementia and beyond2.43Citations (PDF)
4Associations Between Stroke Type, Ischemic Stroke Subtypes, and Poststroke Cognitive Trajectories
Stroke, 2025, 56, 898-907
5.912Citations (PDF)
5Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project
Journal of Alzheimer's Disease, 2025, 104, 841-851
2.62Citations (PDF)
6Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence
Journal of Alzheimer's Disease, 2025, 104, 1064-1074
2.60Citations (PDF)
7Clinical and Imaging Markers of Cardiac Function and Brain Health
Neurology, 2025, 104,
1.011Citations (PDF)
8Hypothalamic Gliosis Is Associated With Multiple Cardiovascular Disease Risk Factors in the Framingham Heart Study4.01Citations (PDF)
9Plasma TAR DNA-binding protein 43 (TDP-43) levels in a population-based cohort of older adults: The cardiovascular health study
Journal of Alzheimer's Disease, 2025, 105, 1275-1281
2.60Citations (PDF)
10Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals
Neurology, 2025, 104,
1.03Citations (PDF)
11Association of MRI-Visible Perivascular Spaces and Incident Depression in the Framingham Heart Study
2025, 1,
1Citations (PDF)
12Long‐Term Incidence of Dementia Following Transient Ischemic Attack: A Longitudinal Cohort Study4.01Citations (PDF)
13Hypertension Trends and White Matter Brain Injury in the Offspring Framingham Heart Study Cohort
Hypertension, 2024, 81, 87-95
6.616Citations (PDF)
14Riemannian frameworks for the harmonization of resting-state functional MRI scans
Medical Image Analysis, 2024, 91, 103043
10.66Citations (PDF)
15Association of Sleep Duration and Change Over Time With Imaging Biomarkers of Cerebrovascular, Amyloid, Tau, and Neurodegenerative Pathology
Neurology, 2024, 102,
1.025Citations (PDF)
16A novel neuroimaging signature for ADRD risk stratification in the community
Alzheimer's and Dementia, 2024, 20, 1881-1893
0.57Citations (PDF)
17Human whole-exome genotype data for Alzheimer’s disease13.73Citations (PDF)
18Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia
Neurology, 2024, 102,
1.026Citations (PDF)
19Trends in Intracranial and Cerebral Volumes of Framingham Heart Study Participants Born 1930 to 1970
JAMA Neurology, 2024, 81, 471
17.627Citations (PDF)
20Association of Neurotrophic Factors at Midlife With In Vivo Measures of β-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults
Neurology, 2024, 102,
1.03Citations (PDF)
21Elevated Plasma Ptau Is Associated with Congestive Heart Failure (P7-9.008)
Neurology, 2024, 102,
1.01Citations (PDF)
22Association of Incident Stroke Risk With an IL-18-Centered Inflammatory Network Biomarker Composite
Stroke, 2024, 55, 1601-1608
5.910Citations (PDF)
23The association between levels of brain‐derived neurotrophic factor and comorbid depression in patients with cardiovascular disease: The Framingham Heart Study3.36Citations (PDF)
24Knockout of the longevity gene Klotho perturbs aging and Alzheimer’s disease-linked brain microRNAs and tRNA fragments4.419Citations (PDF)
25Concurrent nutrient deficiencies are associated with dementia incidence
Alzheimer's and Dementia, 2024, 20, 4594-4601
0.56Citations (PDF)
26Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife
Journal of Alzheimer's Disease, 2024, 100, 935-943
2.65Citations (PDF)
27Genome-wide association study meta-analysis of neurofilament light (NfL) levels in blood reveals novel loci related to neurodegeneration4.46Citations (PDF)
28Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries
Nature Genetics, 2024, 56, 2333-2344
25.220Citations (PDF)
29Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community
Journal of Alzheimer's Disease, 2024, 102, 449-458
2.64Citations (PDF)
30Peripheral risk factors and their role in biomarker‐based screening for dementia in the community
Alzheimer's and Dementia, 2024, 20, 8556-8565
0.52Citations (PDF)
31Sleep Duration and Cognitive Performance in Middle‐Aged and Older Adults: What is the Role of Depression?0.50Citations (PDF)
32APP Gene Duplication Unraveled: A Unique Case of Atypical Dementia with Prominent Psychiatric Concerns in a Hispanic Male0.50Citations (PDF)
33Genotyping transposable element insertions and their novel application in gene mapping strategies for Alzheimer’s disease (AD) endophenotypes0.50Citations (PDF)
34Differential Patterns of Gut and Oral Microbiomes in Patients with Mild‐cognitive Impairment0.50Citations (PDF)
35Relation Between Educational Attainment and Cerebral Small Vessel Disease: the Framingham Heart Study0.50Citations (PDF)
36Towards improved dementia prediction in the population: accounting for peripheral factors associated with levels of AD biomarkers0.50Citations (PDF)
37Are there trends towards compression of morbidity for dementia? Evidences from four international population‐based cohorts0.50Citations (PDF)
38Association of Accelerometer-Measured Physical Activity and Sedentary Time with Epigenetic Markers of Aging0.842Citations (PDF)
39Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: A Texas Alzheimer’s Research and Care Consortium (TARCC) Cohort-Based Analysis2.68Citations (PDF)
40Deep neural network heatmaps capture Alzheimer’s disease patterns reported in a large meta-analysis of neuroimaging studies
NeuroImage, 2023, 269, 119929
4.462Citations (PDF)
41Obesity impacts the expression of Alzheimer's disease–related genes: The Framingham Heart Study
Alzheimer's and Dementia, 2023, 19, 3496-3505
0.524Citations (PDF)
42Inflammatory biomarkers and MRI visible perivascular spaces: The Framingham Heart Study
Neurobiology of Aging, 2023, 127, 12-22
3.415Citations (PDF)
43Association of Mitochondrial DNA Copy Number With Brain MRI Markers and Cognitive Function
Neurology, 2023, 100,
1.036Citations (PDF)
44Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease
Nature Medicine, 2023, 29, 950-962
33.0118Citations (PDF)
45Sex‐specific declines in cholinergic‐targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease
Alzheimer's and Dementia, 2023, 19, 5159-5172
0.537Citations (PDF)
46Lifelong cerebrovascular disease burden among CADASIL patients: analysis from a global health research network2.38Citations (PDF)
47Cerebral small vessel disease burden is associated with decreased abundance of gut Barnesiella intestinihominis bacterium in the Framingham Heart Study
Scientific Reports, 2023, 13,
3.428Citations (PDF)
48Demographic and Clinical Characteristics Associated With Serum GFAP Levels in an Ethnically Diverse Cohort
Neurology, 2023, 101,
1.012Citations (PDF)
49Identification of circulating proteins associated with general cognitive function among middle-aged and older adults4.419Citations (PDF)
50Chromosome 10q24.32 Variants Associate With Brain Arterial Diameters in Diverse Populations: A Genome‐Wide Association Study4.07Citations (PDF)
51Metformin use and stroke risk in Hispanic and non‐Hispanic veteran men with type 2 diabetes0.50Citations (PDF)
52The contribution of vascular risk to amyloid and tau PET deposition in middle‐aged adults from the community0.50Citations (PDF)
53Ultra‐processed food consumption and risk of dementia and Alzheimer’s disease: the Framingham Heart Study0.51Citations (PDF)
54Genomic Studies Across the Lifespan Point to Early Mechanisms Determining Subcortical Volumes1.29Citations (PDF)
55Whole-Genome Sequencing Association Analyses of Stroke and Its Subtypes in Ancestrally Diverse Populations From Trans-Omics for Precision Medicine Project
Stroke, 2022, 53, 875-885
5.937Citations (PDF)
56Low Blood Pressure, Comorbidities, and Ischemic Stroke Mortality in US Veterans
Stroke, 2022, 53, 886-894
5.98Citations (PDF)
57Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study
Epilepsia, 2022, 63, 237-243
4.450Citations (PDF)
58Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study2.610Citations (PDF)
59Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate
Brain, 2022, 145, 1992-2007
8.433Citations (PDF)
60Factors Associated with Apathy in Alzheimer’s Disease: A Cross-Sectional Analysis of the Texas Alzheimer’s Research and Care Consortium (TARCC) Study2.611Citations (PDF)
61Circulating Metabolome and White Matter Hyperintensities in Women and Men
Circulation, 2022, 145, 1040-1052
18.040Citations (PDF)
62Risk Factors, Lifestyle Behaviors, and Vascular Brain Health
Stroke, 2022, 53, 394-403
5.949Citations (PDF)
63Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community
Hypertension, 2022, 79, 505-515
6.6113Citations (PDF)
64Instrumental validation of free water, peak‐width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kits2.469Citations (PDF)
65Grip Strength, Gait Speed and Plasma Markers of Neurodegeneration in Asymptomatic Middle-aged and Older Adults1.315Citations (PDF)
66Blood biomarkers for cognitive decline and clinical progression in a Mexican American cohort2.411Citations (PDF)
67Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study
Journal of Alzheimer's Disease, 2022, 85, 1657-1666
2.615Citations (PDF)
68Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study
Hypertension, 2022, 79, 1045-1056
6.6165Citations (PDF)
69Relations of Metabolic Health and Obesity to Brain Aging in Young to Middle‐Aged Adults4.029Citations (PDF)
70Family history aggregation unit-based tests to detect rare genetic variant associations with application to the Framingham Heart Study6.52Citations (PDF)
71Association of Apolipoprotein E ɛ4 Allele with Enlarged Perivascular Spaces
Annals of Neurology, 2022, 92, 23-31
6.619Citations (PDF)
72Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study
Journal of Alzheimer's Disease, 2022, 86, 1371-1383
2.643Citations (PDF)
73Joint Models for Estimating Determinants of Cognitive Decline in the Presence of Survival Bias
Epidemiology, 2022, 33, 362-371
2.813Citations (PDF)
74Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels4.437Citations (PDF)
75New insights into the genetic etiology of Alzheimer’s disease and related dementias
Nature Genetics, 2022, 54, 412-436
25.22,243Citations (PDF)
76Circulating Interleukin-6 Levels and Incident Ischemic Stroke
Neurology, 2022, 98,
1.082Citations (PDF)
77Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults
Neurology, 2022, 98,
1.028Citations (PDF)
78Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study
Circulation, 2022, 145, 1324-1338
18.069Citations (PDF)
79Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
Annals of Neurology, 2022, 92, 11-22
6.692Citations (PDF)
80Platelet Function Is Associated With Dementia Risk in the Framingham Heart Study4.034Citations (PDF)
81Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults
Journal of Alzheimer's Disease, 2022, 87, 1517-1526
2.629Citations (PDF)
82Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study
Cells, 2022, 11, 1506
4.616Citations (PDF)
83Association of Peripheral Lymphocyte Subsets with Cognitive Decline and Dementia: The Cardiovascular Health Study2.65Citations (PDF)
84Genome-wide association meta-analysis identifies 48 risk variants and highlights the role of the stria vascularis in hearing loss6.575Citations (PDF)
85Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer’s Disease in Predominantly Middle-Aged Adults2.613Citations (PDF)
86Egg consumption and risk of acute stroke in the Million Veteran Program
Clinical Nutrition ESPEN, 2022, 50, 178-182
0.74Citations (PDF)
87Racial and Ethnic Differences in Short- and Long-term Mortality by Stroke Type
Neurology, 2022, 98,
1.013Citations (PDF)
88Red Blood Cell DHA Is Inversely Associated with Risk of Incident Alzheimer’s Disease and All-Cause Dementia: Framingham Offspring Study
Nutrients, 2022, 14, 2408
4.435Citations (PDF)
89Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without Dementia
JAMA Neurology, 2022, 79, 710
17.637Citations (PDF)
90Empirical Dietary Inflammatory Pattern Scores Are Not Associated with Worse Cognitive Performance in the Nurses’ Health Study
Journal of Nutrition, 2022, 152, 2526-2533
2.911Citations (PDF)
91Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning
Molecular Psychiatry, 2022, 27, 4419-4431
7.819Citations (PDF)
92MRI-Visible Perivascular Spaces and Risk of Incident Dementia
Neurology, 2022, 99,
1.044Citations (PDF)
93Association of Red Blood Cell Omega-3 Fatty Acids With MRI Markers and Cognitive Function in Midlife
Neurology, 2022, 99,
1.036Citations (PDF)
94Relations of postural change in blood pressure with hypertension-mediated organ damage in middle-aged adults of the Framingham heart study: A cross-sectional study2.42Citations (PDF)
95Lighter sleep is associated with higher enlarged perivascular spaces burden in middle-aged and elderly individuals
Sleep Medicine, 2022, 100, 558-564
1.631Citations (PDF)
96Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease
Nature Genetics, 2022, 54, 1786-1794
25.2201Citations (PDF)
97Higher Dietary Inflammatory Index scores are not associated with cognitive decline in the Framingham Heart Study0.52Citations (PDF)
98Proteomic profiling of cognitive function in middle‐aged and elderly adults0.50Citations (PDF)
99Association between reproductive factors in women and risk of brain ageing and dementia0.50Citations (PDF)
100Genetic analyses of diffusion MRI phenotypes: a lifespan exploration of cSVD determinants0.50Citations (PDF)
101Association of Plasma NfL Levels with Risk of Cardiovascular Disease in the Framingham Heart Study (S33.005)
Neurology, 2022, 98,
1.07Citations (PDF)
102Circulating Inflammatory Biomarkers and Enlarged Perivascular Spaces: the Framingham Heart Study (P1-1.Virtual)
Neurology, 2022, 98,
1.00Citations (PDF)
103Contribution of Vascular Risk Factors to Dementia and Dementia Risk Prediction Varies Across Mid-to Later-Life: The Framingham Heart Study (P1-1.Virtual)
Neurology, 2022, 98,
1.00Citations (PDF)
104Association of Circulating Metabolites in Plasma or Serum and Risk of Stroke
Neurology, 2021, 96,
1.042Citations (PDF)
105Systemic inflammation as a moderator between sleep and incident dementia
Sleep, 2021, 44,
0.929Citations (PDF)
106Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke16.5119Citations (PDF)
107Cortical superficial siderosis in the general population: The Framingham Heart and Rotterdam studies6.413Citations (PDF)
108Aortic stiffness and cerebral microbleeds: The Framingham Heart Study
Vascular Medicine, 2021, 26, 312-314
2.43Citations (PDF)
109Interleukin-6 Interacts with Sleep Apnea Severity when Predicting Incident Alzheimer’s Disease Dementia
Journal of Alzheimer's Disease, 2021, 79, 1451-1457
2.611Citations (PDF)
110Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Nature, 2021, 590, 290-299
37.92,126Citations (PDF)
111Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank
Alzheimer's and Dementia, 2021, 17, 1422-1431
0.5146Citations (PDF)
112Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease1.832Citations (PDF)
113Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study2.634Citations (PDF)
114Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome‐wide association study in over 12,000 non‐demented participants
Alzheimer's and Dementia, 2021, 17, 1663-1674
0.542Citations (PDF)
115Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function1.322Citations (PDF)
116Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores13.7293Citations (PDF)
117Autonomic Imbalance and Risk of Dementia and Stroke: The Framingham Study
Stroke, 2021, 52, 2068-2076
5.939Citations (PDF)
118Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart Study2.621Citations (PDF)
119Coronary Artery Calcium Assessed Years Before Was Positively Associated With Subtle White Matter Injury of the Brain in Asymptomatic Middle-Aged Men: The Framingham Heart Study2.95Citations (PDF)
120Mind Diet Adherence and Cognitive Performance in the Framingham Heart Study2.658Citations (PDF)
121SARS-CoV-2 Susceptibility and COVID-19 Mortality Among Older Adults With Cognitive Impairment: Cross-Sectional Analysis From Hospital Records in a Diverse US Metropolitan Area2.314Citations (PDF)
122Hearing Function: Identification of New Candidate Genes Further Explaining the Complexity of This Sensory Ability
Genes, 2021, 12, 1228
2.57Citations (PDF)
123Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study
Stroke, 2021, 52,
5.9113Citations (PDF)
124Association of Social Support With Brain Volume and Cognition
JAMA Network Open, 2021, 4, e2121122
6.662Citations (PDF)
125Cognitive Impairment After Intracerebral Hemorrhage: A Systematic Review of Current Evidence and Knowledge Gaps2.345Citations (PDF)
126Digital Peripheral Arterial Tonometry and Cardiovascular Disease Events: The Framingham Heart Study
Stroke, 2021, 52, 2866-2873
5.912Citations (PDF)
127Blood biomarkers for dementia in Hispanic and non‐Hispanic White adults4.824Citations (PDF)
128The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography12.5200Citations (PDF)
129Slow-Wave Sleep and MRI Markers of Brain Aging in a Community-Based Sample
Neurology, 2021, 96,
1.054Citations (PDF)
130The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study3.940Citations (PDF)
131Large‐scale sequencing studies expand the known genetic architecture of Alzheimer's disease2.46Citations (PDF)
132Association of low-frequency and rare coding variants with information processing speed5.22Citations (PDF)
133Non‐alcoholic fatty liver disease, liver fibrosis and patterns of regional amyloid and tau pathology in middle‐aged adults: The Framingham Study0.51Citations (PDF)
134Higher dietary inflammatory index scores are associated with increased incidence of all‐cause dementia in the Framingham Heart Study0.52Citations (PDF)
135Misappraisal of sleep quality is associated with lower cognitive functioning0.51Citations (PDF)
136Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies
Lancet Neurology, The, 2020, 19, 61-70
17.9263Citations (PDF)
137Are large simple trials for dementia prevention possible?
Age and Ageing, 2020, 49, 154-160
1.819Citations (PDF)
138Association of CD14 with incident dementia and markers of brain aging and injury
Neurology, 2020, 94,
1.037Citations (PDF)
139Association Between Blood Pressure Variability and Cerebral Small‐Vessel Disease: A Systematic Review and Meta‐Analysis4.0113Citations (PDF)
140Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta‐analysis consisting 2.8 million adults with 57 294 cases of dementia
Obesity Reviews, 2020, 21,
7.597Citations (PDF)
141Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop
Alzheimer's and Dementia, 2020, 16, 1714-1733
0.5217Citations (PDF)
142Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults13.793Citations (PDF)
143Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study
Neurology, 2020, 95,
1.062Citations (PDF)
144Mid to Late Life Hypertension Trends and Cerebral Small Vessel Disease in the Framingham Heart Study
Hypertension, 2020, 76, 707-714
6.656Citations (PDF)
145Thickness of the cerebral cortex shows positive association with blood levels of triacylglycerols carrying 18-carbon fatty acids4.416Citations (PDF)
146Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia4.056Citations (PDF)
147Exome Array Analysis of Early-Onset Ischemic Stroke
Stroke, 2020, 51, 3356-3360
5.98Citations (PDF)
148Association of common genetic variants with brain microbleeds
Neurology, 2020, 95,
1.090Citations (PDF)
149Bi-directional association between epilepsy and dementia
Neurology, 2020, 95,
1.088Citations (PDF)
150Network analysis to identify proteomic markers for brain aging and dementia in healthy older adults0.50Citations (PDF)
151Higher empirical dietary inflammatory pattern scores are associated with worse cognitive performance in the Nurses’ Health Study0.50Citations (PDF)
152Impaired lung function as a risk factor for accelerated brain ageing0.50Citations (PDF)
153Whole genome sequence association analyses of brain volumes in the TOPMed program0.50Citations (PDF)
154Comparative trans‐ethnic meta‐analysis of whole exome sequencing variation for Alzheimer’s disease (AD) in 18,402 individuals of the Alzheimer’s Disease Sequencing Project (ADSP)0.50Citations (PDF)
155Alzheimer's disease GWAS weighted by multi‐omics and endophenotypes identifies novel risk loci0.56Citations (PDF)
156Decreases in slow wave sleep associate with a higher risk of incident Alzheimer’s disease dementia in a community sample0.50Citations (PDF)
157Frequency of familial Alzheimer’s disease gene mutations within the Alzheimer Disease Sequencing Project (ADSP)0.50Citations (PDF)
158Cerebral small vessel disease genomics and its implications across the lifespan13.7198Citations (PDF)
159The genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages3.625Citations (PDF)
160Joint trajectories of cognition and gait speed in Mexican American and European American older adults: The San Antonio longitudinal study of aging2.218Citations (PDF)
161Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016
JAMA Neurology, 2020, 77, 1252
17.6108Citations (PDF)
162Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities
Stroke, 2020, 51, 2111-2121
5.9114Citations (PDF)
163The genetic architecture of the human cerebral cortex
Science, 2020, 367,
36.3758Citations (PDF)
164Global and Regional Development of the Human Cerebral Cortex: Molecular Architecture and Occupational Aptitudes
Cerebral Cortex, 2020, 30, 4121-4139
2.824Citations (PDF)
165Twenty-seven-year time trends in dementia incidence in Europe and the United States
Neurology, 2020, 95,
1.0435Citations (PDF)
166Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study3.728Citations (PDF)
167Circulating ceramide ratios and risk of vascular brain aging and dementia3.744Citations (PDF)
168The progression of carotid atherosclerosis and imaging markers of dementia4.820Citations (PDF)
169Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project
Genomics, 2019, 111, 808-818
2.860Citations (PDF)
170Whole blood microRNA expression associated with stroke: Results from the Framingham Heart Study
PLoS ONE, 2019, 14, e0219261
2.322Citations (PDF)
171A genome-wide association study identifies genetic loci associated with specific lobar brain volumes4.433Citations (PDF)
172Circulating IGFBP‐2: a novel biomarker for incident dementia3.750Citations (PDF)
173Interrelations Between Arterial Stiffness, Target Organ Damage, and Cardiovascular Disease Outcomes4.0116Citations (PDF)
174Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease
PLoS ONE, 2019, 14, e0218111
2.329Citations (PDF)
175The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)
PLoS ONE, 2019, 14, e0219668
2.368Citations (PDF)
176Plasma total‐tau as a biomarker of stroke risk in the community
Annals of Neurology, 2019, 86, 463-467
6.621Citations (PDF)
177Genome-wide association meta-analysis identifies five novel loci for age-related hearing impairment3.440Citations (PDF)
178Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK92.037Citations (PDF)
179Mid‐life and late‐life vascular risk factor burden and neuropathology in old age3.720Citations (PDF)
180Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke
Circulation Research, 2019, 125, 773-782
13.1107Citations (PDF)
181Distribution of cerebral microbleeds in the East and West
Neurology, 2019, 92,
1.066Citations (PDF)
182Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype
JAMA Neurology, 2019, 76, 1099
17.651Citations (PDF)
183Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham Study
Liver International, 2019, 39, 1713-1721
3.9102Citations (PDF)
184Temporal Trends in Ischemic Stroke Incidence in Younger Adults in the Framingham Study
Stroke, 2019, 50, 1558-1560
5.943Citations (PDF)
185Association of Accelerometer-Measured Light-Intensity Physical Activity With Brain Volume
JAMA Network Open, 2019, 2, e192745
6.6119Citations (PDF)
186Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
PLoS ONE, 2019, 14, e0213321
2.345Citations (PDF)
187Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
JAMA Neurology, 2019, 76, 598
17.6190Citations (PDF)
188Association of variants inHTRA1andNOTCH3with MRI-defined extremes of cerebral small vessel disease in older subjects
Brain, 2019, 142, 1009-1023
8.455Citations (PDF)
189Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration2.485Citations (PDF)
190Full exploitation of high dimensionality in brain imaging: The JPND working group statement and findings2.42Citations (PDF)
191Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts
PLoS ONE, 2019, 14, e0212293
2.3102Citations (PDF)
192Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics, 2019, 51, 414-430
25.22,920Citations (PDF)
193Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer’s Disease Associates with Increased Odds for Brain Infarcts2.69Citations (PDF)
194IC‐P‐087: ASSOCIATION BETWEEN COGNITION AND CEREBRAL WHITE MATTER FREE WATER IN ADULTS FROM THE FRAMINGHAM HEART STUDY: A DIFFUSION TENSOR IMAGING VOXEL‐BASED STUDY0.51Citations (PDF)
195IC‐P‐031: REDUCED STRUCTURAL BRAIN NETWORK MODULARITY IN HEALTHY AGING: RESULTS FROM THE FRAMINGHAM HEART STUDY0.50Citations (PDF)
196Response by Aparicio et al to Letter Regarding Article, “Temporal Trends in Ischemic Stroke Incidence in Younger Adults in the Framingham Study”
Stroke, 2019, 50,
5.90Citations (PDF)
197Genetic architecture of subcortical brain structures in 38,851 individuals
Nature Genetics, 2019, 51, 1624-1636
25.2272Citations (PDF)
198Omega-3 Fatty Acids and Genome-Wide Interaction Analyses Reveal DPP10– Pulmonary Function Association8.919Citations (PDF)
199Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting
Neurology, 2019, 92,
1.043Citations (PDF)
200Vascular dysfunction—The disregarded partner of Alzheimer's disease
Alzheimer's and Dementia, 2019, 15, 158-167
0.5651Citations (PDF)
201A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
Blood, 2019, 133, 967-977
4.851Citations (PDF)
202Metformin Use and Stroke Risk in Hispanic and Non-Hispanic Diabetic Male Veterans (P2.7-001)
Neurology, 2019, 92,
1.00Citations (PDF)
203Are Trends in Dementia Incidence Associated With Compression in Morbidity? Evidence From The Framingham Heart Study2.721Citations (PDF)
204A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure6.5157Citations (PDF)
205Clinical significance of cerebral microbleeds on MRI: A comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1)6.4115Citations (PDF)
206Whole genome sequence analyses of brain imaging measures in the Framingham Study
Neurology, 2018, 90,
1.045Citations (PDF)
207Population Neuroscience1.340Citations (PDF)
208Meta-analysis of epigenome-wide association studies of cognitive abilities
Molecular Psychiatry, 2018, 23, 2133-2144
7.891Citations (PDF)
209Age‐associated microRNA expression in human peripheral blood is associated with all‐cause mortality and age‐related traits
Aging Cell, 2018, 17,
6.8148Citations (PDF)
210Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study
JAMA Neurology, 2018, 75, 97
17.6168Citations (PDF)
211Vascular risk factor burden and new-onset depression in the community
Preventive Medicine, 2018, 111, 348-350
2.818Citations (PDF)
212A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium2.31Citations (PDF)
213Associations of activated coagulation factor VII and factor VIIa‐antithrombin levels with genome‐wide polymorphisms and cardiovascular disease risk3.833Citations (PDF)
214O2‐10‐01: OMEGA‐3 FATTY ACID LEVELS ARE ASSOCIATED WITH BRAIN MRI MEASURES IN MIDDLE‐AGED ADULTS FROM THE FRAMINGHAM HEART STUDY0.50Citations (PDF)
215DT‐02‐05: MARKVCID PHASE II: PRIORITIZED CANDIDATE SMALL VESSEL VCID BIOMARKERS SELECTED FOR INDEPENDENT MULTI‐SITE TESTING AND VALIDATION0.53Citations (PDF)
216O2‐05‐02: IMPACT OF AGE ON THE ASSOCIATION BETWEEN VASCULAR RISK FACTOR BURDEN AND BRAIN VOLUME0.51Citations (PDF)
217P2‐111: INTERACTION BETWEEN ALZHEIMER'S DISEASE GENETIC RISK SCORE AND MIDLIFE PLASMA LIPID LEVELS ON ALZHEIMER ’S DISEASE IN THE FRAMINGHAM HEART STUDY0.50Citations (PDF)
218Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease2.829Citations (PDF)
219IC‐P‐127: CEREBRAL TRACT INTEGRITY RELATES TO WHITE MATTER HYPERINTENSITIES, CORTEX VOLUME, AND COGNITION0.50Citations (PDF)
220P2‐387: CEREBRAL TRACT INTEGRITY RELATES TO WHITE MATTER HYPERINTENSITIES, CORTEX VOLUME, AND COGNITION0.50Citations (PDF)
221IC‐02‐04: REGIONAL ASYMMETRIES IN AMYLOID AND TAU GO TOGETHER: EVIDENCE FOR LOCAL INTERACTION0.51Citations (PDF)
222Genetic Interaction with Plasma Lipids on Alzheimer’s Disease in the Framingham Heart Study
Journal of Alzheimer's Disease, 2018, 66, 1275-1282
2.69Citations (PDF)
223APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality
Stroke, 2018, 49, 2822-2829
5.953Citations (PDF)
224P3‐561: ADHERENCE TO THE MIND DIET IS ASSOCIATED WITH BETTER COGNITION IN THE FRAMINGHAM HEART STUDY0.50Citations (PDF)
225O3‐11‐01: USE OF BLOOD PRESSURE–LOWERING DRUGS AND RISK OF INCIDENT DEMENTIA AND ALZHEIMER'S DISEASE IN OLDER PEOPLE WITH AND WITHOUT HIGH BLOOD PRESSURE: A META‐ANALYSIS OF INDIVIDUAL PARTICIPANT DATA FROM PROSPECTIVE COHORT STUDIES0.50Citations (PDF)
226GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes13.7168Citations (PDF)
227Genome-wide association study of 23,500 individuals identifies 7 loci associated with brain ventricular volume13.753Citations (PDF)
228Vascular risk at younger ages most strongly associates with current and future brain volume
Neurology, 2018, 91,
1.052Citations (PDF)
229Circulating Vascular Growth Factors and Magnetic Resonance Imaging Markers of Small Vessel Disease and Atrophy in Middle-Aged Adults
Stroke, 2018, 49, 2227-2229
5.917Citations (PDF)
230Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke
PLoS ONE, 2018, 13, e0206554
2.310Citations (PDF)
231Circulating cortisol and cognitive and structural brain measures
Neurology, 2018, 91,
1.0123Citations (PDF)
232Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function13.7650Citations (PDF)
233Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats12.5178Citations (PDF)
234Analysis of shared heritability in common disorders of the brain
Science, 2018, 360,
36.31,393Citations (PDF)
235Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging
Stroke, 2018, 49, 1812-1819
5.924Citations (PDF)
236DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons
JAMA Psychiatry, 2018, 75, 949
12.4107Citations (PDF)
237Cerebral tract integrity relates to white matter hyperintensities, cortex volume, and cognition
Neurobiology of Aging, 2018, 72, 14-22
3.451Citations (PDF)
238Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer’s Disease
Journal of Alzheimer's Disease, 2018, 63, 1433-1443
2.69Citations (PDF)
239Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation
Molecular Psychiatry, 2018, 25, 1859-1875
7.8233Citations (PDF)
240Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes
Nature Genetics, 2018, 50, 524-537
25.21,600Citations (PDF)
241Physical Activity, Brain Volume, and Dementia Risk: The Framingham Study3.4133Citations (PDF)
242Novel genetic loci associated with hippocampal volume13.7297Citations (PDF)
243Revised Framingham Stroke Risk Profile to Reflect Temporal Trends
Circulation, 2017, 135, 1145-1159
18.0215Citations (PDF)
244Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia
Neurology, 2017, 88, 1172-1179
1.0188Citations (PDF)
245Left ventricular hypertrophy in association with cognitive impairment: a systematic review and meta-analysis
Hypertension Research, 2017, 40, 696-709
3.021Citations (PDF)
246Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study
Neurobiology of Aging, 2017, 54, 94-99
3.477Citations (PDF)
247Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia
Stroke, 2017, 48, 1139-1146
5.9170Citations (PDF)
248The changing prevalence and incidence of dementia over time — current evidence
Nature Reviews Neurology, 2017, 13, 327-339
28.6712Citations (PDF)
249Aortic Stiffness, Increased White Matter Free Water, and Altered Microstructural Integrity
Stroke, 2017, 48, 1567-1573
5.9133Citations (PDF)
250Response by Lubitz et al to Letter Regarding Article, “Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study”
Stroke, 2017, 48,
5.91Citations (PDF)
251A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease
Nature Neuroscience, 2017, 20, 1052-1061
17.1426Citations (PDF)
252Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke
Stroke, 2017, 48, 1760-1765
5.970Citations (PDF)
253Response by Pase et al to Letter Regarding Article, “Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia: A Prospective Cohort Study”
Stroke, 2017, 48,
5.90Citations (PDF)
254Role of Improved Vascular Health in the Declining Incidence of Dementia
Stroke, 2017, 48, 2013-2020
5.941Citations (PDF)
255Incidence of seizures following initial ischemic stroke in a community-based cohort: The Framingham Heart Study2.165Citations (PDF)
256Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation
Alzheimer's and Dementia, 2017, 13, 267-273
0.539Citations (PDF)
257Genetic variation at 16q24.2 is associated with small vessel stroke
Annals of Neurology, 2017, 81, 383-394
6.685Citations (PDF)
258Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke, 2017, 48,
5.9373Citations (PDF)
259Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium5.324Citations (PDF)
260COL4A2 is associated with lacunar ischemic stroke and deep ICH
Neurology, 2017, 89, 1829-1839
1.077Citations (PDF)
261Sleep architecture and the risk of incident dementia in the community
Neurology, 2017, 89, 1244-1250
1.0240Citations (PDF)
262Response by Pase et al to Letter Regarding Article, “Sweetened Beverages and the Risks of Incident Stroke and Dementia”
Stroke, 2017, 48,
5.90Citations (PDF)
263Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association
Stroke, 2017, 48,
5.9387Citations (PDF)
264Inter‐Relations of Orthostatic Blood Pressure Change, Aortic Stiffness, and Brain Structure and Function in Young Adults4.022Citations (PDF)
265Response by Pase et al to Letters Regarding Article, “Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia. A Prospective Cohort Study”
Stroke, 2017, 48,
5.90Citations (PDF)
266Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Nature Genetics, 2017, 49, 1373-1384
25.2998Citations (PDF)
267Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer’s Disease Patients2.624Citations (PDF)
268Blood pressure from mid‐ to late life and risk of incident dementia
Neurology, 2017, 89, 2447-2454
1.0263Citations (PDF)
269Overweight, Obesity, and Survival After Stroke in the Framingham Heart Study4.041Citations (PDF)
270Association of descending thoracic aortic plaque with brain atrophy and white matter hyperintensities: The Framingham Heart Study
Atherosclerosis, 2017, 265, 305-311
1.521Citations (PDF)
271Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypes
Neurology, 2017, 89, 454-460
1.0106Citations (PDF)
272Serum brain-derived neurotrophic factor and risk of atrial fibrillation
American Heart Journal, 2017, 183, 69-73
2.914Citations (PDF)
273[P3–241]: MRI FINDINGS ASSOCIATED WITH CIRCULATING VEGF AND STIE2 CONCENTRATIONS IN YOUNG AND MIDDLE‐AGED ADULTS IN THE FRAMINGHAM HEART STUDY0.50Citations (PDF)
274[IC‐P‐102]: CIRCULATING VEGF AND STIE2 AND MRI FINDINGS IN YOUNG AND MIDDLE‐AGED ADULTS IN THE FRAMINGHAM HEART STUDY0.50Citations (PDF)
275[O1–11–04]: TOPMED WHOLE GENOME SEQUENCE (WGS) ASSOCIATIONS WITH BRAIN MRI MEASURES IN THE FRAMINGHAM STUDY0.50Citations (PDF)
276[O3–05–06]: REM SLEEP MECHANISMS PREDICT INCIDENT DEMENTIA IN THE FRAMINGHAM HEART STUDY0.53Citations (PDF)
277[P3–090]: THE ALZHEIMER's DISEASE SEQUENCING PROJECT (ADSP) DATA UPDATE 20170.50Citations (PDF)
278Whole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study
PLoS ONE, 2017, 12, e0180046
2.323Citations (PDF)
279APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
PLoS Medicine, 2017, 14, e1002254
8.0154Citations (PDF)
280Whole blood gene expression and white matter Hyperintensities14.135Citations (PDF)
281Blood Pressure Trajectories from Mid to Late Life and Risk of Dementia: The Framingham Study (S49.003)
Neurology, 2017, 88,
1.00Citations (PDF)
282Lifelong Reading Disorder and Mild Cognitive Impairment: Implications for Diagnosis2.68Citations (PDF)
283Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia
Diabetes Care, 2016, 39, 300-307
6.2628Citations (PDF)
284Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke/subtitle
Thrombosis and Haemostasis, 2016, 116, 1165-1771
4.17Citations (PDF)
285Pulse Pressure Is Associated With Early Brain Atrophy and Cognitive Decline1.347Citations (PDF)
286Circulating vascular endothelial growth factor and the risk of cardiovascular events
Heart, 2016, 102, 1898-1901
3.921Citations (PDF)
287Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer’s Disease Pathology
Journal of Alzheimer's Disease, 2016, 53, 1553-1562
2.629Citations (PDF)
288Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study
Journal of Alzheimer's Disease, 2016, 53, 1597-1608
2.667Citations (PDF)
289Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study2.6116Citations (PDF)
290F1‐01‐02: Alzheimer's Disease Sequencing Project: Search for Alzheimer's Disease Resilience Genes That May Modify Disease Susceptibility in Specific Apoe Genotype Backgrounds0.50Citations (PDF)
291P2‐097: The Alzheimer’s Disease Sequencing Project (ADSP): Data Production, Management, and Availability0.50Citations (PDF)
292FTS3‐02‐01: Epidemiological Bases0.50Citations (PDF)
293P2‐077: Alzheimer's Disease Sequencing Project: Search for Alzheimer's Disease Resilience Genes That May Modify Disease Susceptibility in Specific Apoe Genotype Backgrounds0.50Citations (PDF)
294P3‐297: CVD is Pathologically Associated with Greater Alzheimer's Disease in Non‐Demented Older Adults0.50Citations (PDF)
295FTS3‐01‐02: Epidemiology of Vascular Related Risk Factors for Dementia0.50Citations (PDF)
296O1‐02‐01: Non‐Alcoholic Fatty Liver Disease is Associated with Lower Brain Volume in Healthy Middle‐Aged Adults: the Framingham Study0.50Citations (PDF)
297O2‐09‐01: Aortic Stiffness and the Risk of Incident Mild Cognitive Impairment and Dementia0.50Citations (PDF)
298O2‐10‐06: A Common Allele in SPI1 Lowers Risk and Delays Age at Onset for Alzheimer's Disease0.50Citations (PDF)
299P1‐019: Large‐Scale Meta‐Analysis of Genome‐Wide Association Data on Delayed Recall Memory Performance: The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium0.50Citations (PDF)
300P1‐118: Association of Low‐Frequency and Rare Coding Variants with Information Processing Speed0.50Citations (PDF)
301Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer’s Disease2.697Citations (PDF)
302Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study)
American Heart Journal, 2016, 177, 138-144
2.941Citations (PDF)
303Neck Circumference, Brain Imaging Measures, and Neuropsychological Testing Measures1.64Citations (PDF)
304Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease4.788Citations (PDF)
305Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies
Lancet Neurology, The, 2016, 15, 695-707
17.9157Citations (PDF)
306Low-frequency and common genetic variation in ischemic stroke
Neurology, 2016, 86, 1217-1226
1.0161Citations (PDF)
307Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia
Stroke, 2016, 47, 1201-1206
5.9136Citations (PDF)
308Novel genetic loci underlying human intracranial volume identified through genome-wide association
Nature Neuroscience, 2016, 19, 1569-1582
17.1240Citations (PDF)
309Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
Hypertension, 2016, 68,
6.6653Citations (PDF)
310GWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortium
Aging Cell, 2016, 15, 792-800
6.865Citations (PDF)
311Aortic Stiffness and the Risk of Incident Mild Cognitive Impairment and Dementia
Stroke, 2016, 47, 2256-2261
5.9149Citations (PDF)
312Genomewide meta‐analysis identifies loci associated with IGF ‐I and IGFBP ‐3 levels with impact on age‐related traits
Aging Cell, 2016, 15, 811-824
6.889Citations (PDF)
313Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke2.437Citations (PDF)
314Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study
Neurology, 2016, 87, 1206-1211
1.053Citations (PDF)
315O2‐10‐02: Genetic Determinants of MRI Subcortical Brain Structures: 24 Novel Loci Identified Through Gwas in 26,000 Persons0.50Citations (PDF)
316Incidence of Dementia over Three Decades in the Framingham Heart Study34.583Citations (PDF)
317Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study
Experimental Aging Research, 2016, 42, 315-328
1.741Citations (PDF)
318Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology1.836Citations (PDF)
319Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2
Stroke, 2016, 47, 307-316
5.960Citations (PDF)
320Association of arterial stiffness with progression of subclinical brain and cognitive disease
Neurology, 2016, 86, 619-626
1.0120Citations (PDF)
321Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study
Lancet Neurology, The, 2016, 15, 174-184
17.9244Citations (PDF)
322Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study4.047Citations (PDF)
323Midlife exercise blood pressure, heart rate, and fitness relate to brain volume 2 decades later
Neurology, 2016, 86, 1313-1319
1.026Citations (PDF)
324Incidence of Dementia over Three Decades in the Framingham Heart Study34.5969Citations (PDF)
325Silent Brain Infarction and Risk of Future Stroke
Stroke, 2016, 47, 719-725
5.9218Citations (PDF)
326Effects of Arterial Stiffness on Brain Integrity in Young Adults From the Framingham Heart Study
Stroke, 2016, 47, 1030-1036
5.9117Citations (PDF)
327Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke
Neurology, 2016, 86, 351-359
1.038Citations (PDF)
328Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury
Stroke, 2016, 47, 383-389
5.919Citations (PDF)
329Association of Aortic Stiffness With Cognition and Brain Aging in Young and Middle-Aged Adults
Hypertension, 2016, 67, 513-519
6.6153Citations (PDF)
330Polygenic risk of ischemic stroke is associated with cognitive ability
Neurology, 2016, 86, 611-618
1.014Citations (PDF)
331Fitness and cognition in the elderly
Neurology, 2016, 86, 418-424
1.078Citations (PDF)
332Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study
Heart Rhythm, 2016, 13, 233-240
2.776Citations (PDF)
333Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies
PLoS Genetics, 2016, 12, e1005874
3.264Citations (PDF)
334Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease
PLoS Genetics, 2016, 12, e1006327
3.254Citations (PDF)
335O4‐05‐02: Genome‐wide association study of lobar brain volumes0.50Citations (PDF)
336O1‐04‐06: Association of plasma biomarkers with risk of incident dementia in the framingham heart study: A metabolomics approach0.50Citations (PDF)
337Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study2.611Citations (PDF)
338Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
Journal of Hepatology, 2015, 63, 470-476
4.2199Citations (PDF)
339Shared genetic basis for migraine and ischemic stroke
Neurology, 2015, 84, 2132-2145
1.0113Citations (PDF)
340A priori collaboration in population imaging: The Uniform Neuro‐Imaging of Virchow‐Robin Spaces Enlargement consortium2.452Citations (PDF)
341S1‐01‐04: Vascular contributions to cognitive impairment0.51Citations (PDF)
342O1‐10‐03: APOE risk in the Alzheimer's prevention initiative0.50Citations (PDF)
343O4‐05‐03: Whole exome sequence analysis of white matter hyperintensities on cranial MRI0.52Citations (PDF)
344Validation of Secondary Data Sources to Identify Parkinson Disease Against Clinical Diagnostic Criteria3.321Citations (PDF)
345Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease
Neurology, 2015, 84, 918-926
1.0130Citations (PDF)
346Lipid and lipoprotein measurements and the risk of ischemic vascular events
Neurology, 2015, 84, 472-479
1.078Citations (PDF)
347Common genetic variants influence human subcortical brain structures
Nature, 2015, 520, 224-229
37.9895Citations (PDF)
348Association of Alzheimer's disease GWAS loci with MRI markers of brain aging
Neurobiology of Aging, 2015, 36, 1765.e7-1765.e16
3.4102Citations (PDF)
349Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949)
Molecular Psychiatry, 2015, 20, 183-192
7.8390Citations (PDF)
350Genetic Overlap Between Diagnostic Subtypes of Ischemic Stroke
Stroke, 2015, 46, 615-619
5.938Citations (PDF)
351APOE and mild cognitive impairment: the Framingham Heart Study
Age and Ageing, 2015, 44, 307-311
1.825Citations (PDF)
352Normative Data for the Cognitively Intact Oldest-Old: The Framingham Heart Study
Experimental Aging Research, 2015, 41, 386-409
1.721Citations (PDF)
353Directional dominance on stature and cognition in diverse human populations
Nature, 2015, 523, 459-462
37.9199Citations (PDF)
354Glucose indices are associated with cognitive and structural brain measures in young adults
Neurology, 2015, 84, 2329-2337
1.0143Citations (PDF)
355Genetic Factors Influencing Coagulation Factor XIII B-Subunit Contribute to Risk of Ischemic Stroke
Stroke, 2015, 46, 2069-2074
5.915Citations (PDF)
356Long-Term Exposure to Fine Particulate Matter, Residential Proximity to Major Roads and Measures of Brain Structure
Stroke, 2015, 46, 1161-1166
5.9249Citations (PDF)
357Inflammatory biomarkers, cerebral microbleeds, and small vessel disease
Neurology, 2015, 84, 825-832
1.0218Citations (PDF)
358Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI3.8186Citations (PDF)
359Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke
JAMA Neurology, 2015, 72, 781
17.659Citations (PDF)
360Verbal Memory and Brain Aging2.06Citations (PDF)
361GWAS of Longevity in CHARGE Consortium Confirms APOE and FOXO3 Candidacy3.4288Citations (PDF)
36250 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
Lancet, The, 2015, 386, 154-162
62.11,615Citations (PDF)
363Low Cardiac Index Is Associated With Incident Dementia and Alzheimer Disease
Circulation, 2015, 131, 1333-1339
18.0164Citations (PDF)
364Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease
Circulation, 2015, 131, 2061-2069
18.0160Citations (PDF)
365Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke
Stroke, 2015, 46, 2568-2575
5.972Citations (PDF)
366Circulating Brain‐Derived Neurotrophic Factor Concentrations and the Risk of Cardiovascular Disease in the Community4.0134Citations (PDF)
367Common polygenic variation enhances risk prediction for Alzheimer’s disease
Brain, 2015, 138, 3673-3684
8.4437Citations (PDF)
368Spectrum of cognition short of dementia
Neurology, 2015, 85, 1712-1721
1.082Citations (PDF)
369White Matter Lesion Progression
Stroke, 2015, 46, 3048-3057
5.929Citations (PDF)
370Serum Leptin Levels and the Risk of Stroke
Stroke, 2015, 46, 2881-2885
5.930Citations (PDF)
371Genes From a Translational Analysis Support a Multifactorial Nature of White Matter Hyperintensities
Stroke, 2015, 46, 341-347
5.941Citations (PDF)
372Genome-wide Studies of Verbal Declarative Memory in Nondemented Older People: The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium
Biological Psychiatry, 2015, 77, 749-763
5.474Citations (PDF)
373Evaluation of power of the Illumina HumanOmni5M-4v1 BeadChip to detect risk variants for human complex diseases3.08Citations (PDF)
374GWAS for executive function and processing speed suggests involvement of the CADM2 gene
Molecular Psychiatry, 2015, 21, 189-197
7.8145Citations (PDF)
375A novel Alzheimer disease locus located near the gene encoding tau protein
Molecular Psychiatry, 2015, 21, 108-117
7.8313Citations (PDF)
376Mid-life Cardiovascular Risk Impacts Memory Function1.329Citations (PDF)
377Protein Expression of Alzheimer's disease‐ and Reduced Hippocampal Volume‐ Risk Loci in Human Hippocampus
FASEB Journal, 2015, 29,
0.60Citations (PDF)
378Cardiovascular Risk Profile in Women and Dementia
Journal of Alzheimer's Disease, 2014, 42, S353-S363
2.638Citations (PDF)
379Parental longevity is associated with cognition and brain ageing in middle-aged offspring
Age and Ageing, 2014, 43, 358-363
1.824Citations (PDF)
380Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia
JAMA Neurology, 2014, 71, 55
17.6275Citations (PDF)
381Genome-Wide Meta-Analysis of Homocysteine and Methionine Metabolism Identifies Five One Carbon Metabolism Loci and a Novel Association of ALDH1L1 with Ischemic Stroke
PLoS Genetics, 2014, 10, e1004214
3.275Citations (PDF)
382O4‐04‐05: ASSOCIATION OF ALZHEIMER DISEASE GWAS LOCI WITH MRI‐MARKERS OF BRAIN AGING0.50Citations (PDF)
383Midlife Cardiovascular Risk Impacts Executive Function1.341Citations (PDF)
384Association Between Neuropathology and Brain Volume in The Framingham Heart Study1.333Citations (PDF)
385Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol6.5207Citations (PDF)
386Predicting Stroke Through Genetic Risk Functions
Stroke, 2014, 45, 403-412
5.969Citations (PDF)
387Multilocus Genetic Risk Score Associates With Ischemic Stroke in Case–Control and Prospective Cohort Studies
Stroke, 2014, 45, 394-402
5.963Citations (PDF)
388Shared Genetic Susceptibility to Ischemic Stroke and Coronary Artery Disease
Stroke, 2014, 45, 24-36
5.9333Citations (PDF)
389Cognitive Performance after Stroke – The Framingham Heart Study6.444Citations (PDF)
390Genome-Wide Association Study of l -Arginine and Dimethylarginines Reveals Novel Metabolic Pathway for Symmetric Dimethylarginine3.859Citations (PDF)
391Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12
Neurology, 2014, 83, 678-685
1.095Citations (PDF)
392Determination of Chorionicity in Twins: Feasibility at a Tertiary Care Centre and Audit of Current Practice in the Community
Journal of Fetal Medicine, 2014, 01, 29-32
0.10Citations (PDF)
393Circulating biomarkers that predict incident dementia6.515Citations (PDF)
394Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy
Neurology, 2014, 82, 1613-1619
1.0214Citations (PDF)
395F4‐04‐03: DO THE VARIANTS IDENTIFIED IN IGAP IMPROVE RISK PREDICTION OF ALZHEIMER'S DISEASE?0.50Citations (PDF)
396P1‐315: INFLUENCE OF MIDLIFE ELEVATED BLOOD GLUCOSE AND APOE GENOTYPE ON VASCULAR AND ALZHEIMER'S DISEASE NEUROPATHOLOGY0.50Citations (PDF)
397P1‐327: NEUROPSYCHOLOGICAL CRITERIA FOR MCI AND DEMENTIA RISK IN THE FRAMINGHAM HEART STUDY0.50Citations (PDF)
398O4‐04‐01: GENE EXPRESSION NETWORK ANALYSIS IMPLICATES THE IMMUNE RESPONSE IN GENETIC SUSCEPTIBILITY TO LATE‐ONSET AD0.50Citations (PDF)
399O5‐03‐05: TEMPORAL TRENDS IN DEMENTIA INCIDENCE IN THE FRAMINGHAM STUDY0.55Citations (PDF)
400P3‐071: A GENOME‐WIDE META‐ANALYSIS OF PLASMA CLUSTERIN LEVELS IN THE CHARGE CONSORTIUM0.50Citations (PDF)
401P3‐136: LOW CARDIAC INDEX IS ASSOCIATED WITH INCIDENT DEMENTIA AND ALZHEIMER'S DISEASE: THE FRAMINGHAM HEART STUDY0.51Citations (PDF)
402P1‐339: DETECTING PRE‐MILD COGNITIVE IMPAIRMENT: COMBINING MRI AND MEMORY TEST PERFORMANCE0.50Citations (PDF)
403Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
PLoS ONE, 2014, 9, e94661
2.3165Citations (PDF)
404Associations of NINJ2 Sequence Variants with Incident Ischemic Stroke in the Cohorts for Heart and Aging in Genomic Epidemiology (CHARGE) Consortium
PLoS ONE, 2014, 9, e99798
2.314Citations (PDF)
405Risk Estimations, Risk Factors, and Genetic Variants Associated with Alzheimer's Disease in Selected Publications from the Framingham Heart Study
Journal of Alzheimer's Disease, 2013, 33, S439-S445
2.623Citations (PDF)
406Apolipoprotein Epsilon 4 Allele Modifies Waist-to-Hip Ratio Effects on Cognition and Brain Structure1.636Citations (PDF)
407APOE Genotype Modifies the Relationship between Midlife Vascular Risk Factors and Later Cognitive Decline1.6100Citations (PDF)
408Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Nature Genetics, 2013, 45, 1452-1458
25.24,413Citations (PDF)
409Serum Brain–Derived Neurotrophic Factor and Vascular Endothelial Growth Factor Levels Are Associated With Risk of Stroke and Vascular Brain Injury
Stroke, 2013, 44, 2768-2775
5.9151Citations (PDF)
410Ischemic stroke is associated with the ABO locus: The EuroCLOT study
Annals of Neurology, 2013, 73, 16-31
6.6157Citations (PDF)
411Vitamin D concentration and lateral cerebral ventricle volume in older adults4.068Citations (PDF)
412APOE genotype and MRI markers of cerebrovascular disease
Neurology, 2013, 81, 292-300
1.0177Citations (PDF)
413Qualitative Neuropsychological Measures: Normative Data on Executive Functioning Tests from the Framingham Offspring Study
Experimental Aging Research, 2013, 39, 515-535
1.720Citations (PDF)
414Brain Imaging and Cognitive Predictors of Stroke and Alzheimer Disease in the Framingham Heart Study
Stroke, 2013, 44, 2787-2794
5.951Citations (PDF)
415Neck Circumference, Carotid Wall Intima-Media Thickness, and Incident Stroke
Diabetes Care, 2013, 36, e153-e154
6.225Citations (PDF)
416Lexical retrieval in discourse: An early indicator of Alzheimer’s dementia1.240Citations (PDF)
417Relations of arterial stiffness and endothelial function to brain aging in the community
Neurology, 2013, 81, 984-991
1.0240Citations (PDF)
418Defining MCI in the Framingham Heart Study Offspring1.317Citations (PDF)
419Multiethnic Meta-Analysis of Genome-Wide Association Studies in >100 000 Subjects Identifies 23 Fibrinogen-Associated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease
Circulation, 2013, 128, 1310-1324
18.0142Citations (PDF)
420The Framingham Heart Study Clock Drawing Performance: Normative Data from the Offspring Cohort
Experimental Aging Research, 2013, 39, 80-108
1.727Citations (PDF)
421Transient Global Amnesia and Neurological Events: The Framingham Heart Study2.320Citations (PDF)
422Folate status in relation to cognitive function and decline in a population with high folic acid intake
FASEB Journal, 2013, 27,
0.60Citations (PDF)
423Constructional Apraxia Reversed With Methylprednisolone2.31Citations (PDF)
424Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease
Archives of Neurology, 2012, 69, 594
6.8190Citations (PDF)
425Common variants at 6q22 and 17q21 are associated with intracranial volume
Nature Genetics, 2012, 44, 539-544
25.2131Citations (PDF)
426Common variants at 12q14 and 12q24 are associated with hippocampal volume
Nature Genetics, 2012, 44, 545-551
25.2225Citations (PDF)
427Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study
BMJ: British Medical Journal, 2012, 344, e1442-e1442
0.1389Citations (PDF)
428Common variants at 12q15 and 12q24 are associated with infant head circumference
Nature Genetics, 2012, 44, 532-538
25.2136Citations (PDF)
429Increased Expression of TrkB and Capzb2 Accompanies Preserved Cognitive Status in Early Alzheimer Disease Pathology1.827Citations (PDF)
430Identification of common variants associated with human hippocampal and intracranial volumes
Nature Genetics, 2012, 44, 552-561
25.2648Citations (PDF)
431No association of ALOX5AP polymorphisms with risk of MRI-defined brain infarcts
Neurobiology of Aging, 2012, 33, 629.e1-629.e3
3.48Citations (PDF)
432Homocysteine and the Risk of Dementia
Clinical Chemistry, 2012, 58, 1059-1060
1.119Citations (PDF)
433Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies
Lancet Neurology, The, 2012, 11, 951-962
17.9487Citations (PDF)
434Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study
Lancet Neurology, The, 2012, 11, 1039-1047
17.9312Citations (PDF)
435Using Family-Based Imputation in Genome-Wide Association Studies with Large Complex Pedigrees: The Framingham Heart Study
PLoS ONE, 2012, 7, e51589
2.317Citations (PDF)
436Association between genetic variant on chromosome 12p13 and stroke survival and recurrence: a one year prospective study in Taiwan10.897Citations (PDF)
437Multiple Biomarkers and Risk of Clinical and Subclinical Vascular Brain Injury
Circulation, 2012, 125, 2100-2107
18.067Citations (PDF)
438δ-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes
PLoS ONE, 2012, 7, e43728
2.368Citations (PDF)
439O3‐01‐01: Genome‐wide association studies of hippocampal volume: The CHARGE consortium0.50Citations (PDF)
440Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Nature, 2011, 478, 103-109
37.92,008Citations (PDF)
441Vascular Contributions to Cognitive Impairment and Dementia
Stroke, 2011, 42, 2672-2713
5.93,668Citations (PDF)
442A genome-wide association study of aging
Neurobiology of Aging, 2011, 32, 2109.e15-2109.e28
3.4138Citations (PDF)
443PL‐01‐01: Genetic studies of Alzheimer's disease0.50Citations (PDF)
444Association of HSP70 and its Co-Chaperones with Alzheimer's Disease2.624Citations (PDF)
445Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Nature Genetics, 2011, 43, 429-435
25.21,938Citations (PDF)
446Genome‐wide association studies of cerebral white matter lesion burden
Annals of Neurology, 2011, 69, 928-939
6.6228Citations (PDF)
447Identification of cis - and trans -Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels
Circulation Research, 2011, 109, 554-563
13.184Citations (PDF)
448Large-Scale Candidate Gene Analysis in Whites and African Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation3.883Citations (PDF)
449Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study
Human Molecular Genetics, 2011, 20, 2273-2284
2.9169Citations (PDF)
450The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort4.7153Citations (PDF)
451Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults
Diabetes Care, 2011, 34, 1766-1770
6.2131Citations (PDF)
452Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
Neurology, 2011, 77, 461-468
1.0726Citations (PDF)
453Genome-Wide Association Studies of MRI-Defined Brain Infarcts
Stroke, 2010, 41, 210-217
5.985Citations (PDF)
454Visceral fat is associated with lower brain volume in healthy middle‐aged adults
Annals of Neurology, 2010, 68, 136-144
6.6232Citations (PDF)
455Reply
Annals of Neurology, 2010, 68, 771-772
6.623Citations (PDF)
456Modulators of Cytoskeletal Reorganization in CA1 Hippocampal Neurons Show Increased Expression in Patients at Mid-Stage Alzheimer's Disease
PLoS ONE, 2010, 5, e13337
2.321Citations (PDF)
457Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease16.51,149Citations (PDF)
458Profiles by Sex of Brain MRI and Cognitive Function in the Framingham Offspring Study1.316Citations (PDF)
459Parental Occurrence of Stroke and Risk of Stroke in Their Children
Circulation, 2010, 121, 1304-1312
18.0142Citations (PDF)
460Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and Mortality
Stroke, 2010, 41, 600-606
5.9486Citations (PDF)
461Cardiac Index Is Associated With Brain Aging
Circulation, 2010, 122, 690-697
18.0249Citations (PDF)
462A Meta-analysis of Four Genome-Wide Association Studies of Survival to Age 90 Years or Older: The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium3.4125Citations (PDF)
463Interactive Effects of Apolipoprotein E Type 4 Genotype and Cerebrovascular Risk on Neuropsychological Performance and Structural Brain Changes1.638Citations (PDF)
464Association of matrix metalloproteinases with MRI indices of brain ischemia and aging
Neurobiology of Aging, 2010, 31, 2128-2135
3.434Citations (PDF)
465Depressive symptoms and risk of dementia
Neurology, 2010, 75, 35-41
1.0458Citations (PDF)
466Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?6.536Citations (PDF)
467Genomewide Association Studies of Stroke
New England Journal of Medicine, 2009, 360, 1718-1728
34.5433Citations (PDF)
468Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study
Stroke, 2009, 40, 1032-1037
5.9597Citations (PDF)
469Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort
Stroke, 2009, 40, 2715-2719
5.945Citations (PDF)
470Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury
Stroke, 2009, 40, 2959-2964
5.984Citations (PDF)
471Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging16.5401Citations (PDF)
472Association of parental dementia with cognitive and brain MRI measures in middle-aged adults
Neurology, 2009, 73, 2071-2078
1.078Citations (PDF)
473Genetics of Atherothrombotic and Lacunar Stroke3.89Citations (PDF)
474Response to Letter by Tsuda
Stroke, 2009, 40,
5.90Citations (PDF)
475Bivariate Heritability of Total and Regional Brain Volumes1.327Citations (PDF)
476Carotid Artery Atherosclerosis, MRI Indices of Brain Ischemia, Aging, and Cognitive Impairment
Stroke, 2009, 40, 1590-1596
5.9302Citations (PDF)
477Association of Carotid Artery Atherosclerosis With Circulating Biomarkers of Extracellular Matrix Remodeling: The Framingham Offspring Study1.638Citations (PDF)
478Thyroid Function and the Risk of Alzheimer Disease<subtitle>The Framingham Study</subtitle>8.1206Citations (PDF)
479Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study
Stroke, 2008, 39, 2929-2935
5.9290Citations (PDF)
480Association of Alcohol Consumption With Brain Volume in the Framingham Study6.8147Citations (PDF)
481Association of Plasma Total Homocysteine Levels With Subclinical Brain Injury6.8154Citations (PDF)
482Diabetes and stroke1.72Citations (PDF)
483Left Ventricular Mass, Blood Pressure, and Lowered Cognitive Performance in the Framingham Offspring
Hypertension, 2007, 49, 439-445
6.666Citations (PDF)
484Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study1.8178Citations (PDF)
485Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study1.8186Citations (PDF)
486Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes1.8162Citations (PDF)
487Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study
Lancet Neurology, The, 2007, 6, 1106-1114
17.9344Citations (PDF)
488Atrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men1.679Citations (PDF)
489Visual Association Pathology in Preclinical Alzheimer Disease1.8161Citations (PDF)
490Association of White Matter Hyperintensity Volume With Decreased Cognitive Functioning
Archives of Neurology, 2006, 63, 246
6.8365Citations (PDF)
491Elevated plasma homocysteine levels: Risk factor or risk marker for the development of dementia and Alzheimer's disease?2.6169Citations (PDF)
492Trends in Incidence, Lifetime Risk, Severity, and 30-Day Mortality of Stroke Over the Past 50 Years16.5448Citations (PDF)
493Diabetes Mellitus and Risk of Developing Alzheimer Disease
Archives of Neurology, 2006, 63, 1551
6.8262Citations (PDF)
494The Lifetime Risk of Stroke
Stroke, 2006, 37, 345-350
5.9676Citations (PDF)
495Methodology for measuring cerebrovascular disease burden2.614Citations (PDF)
496Bone Mineral Density and the Risk of Alzheimer Disease
Archives of Neurology, 2005, 62, 107
6.8122Citations (PDF)
497Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important3.3130Citations (PDF)
498Framingham Stroke Risk Profile and Lowered Cognitive Performance
Stroke, 2004, 35, 404-409
5.9231Citations (PDF)
499New Norms for a New Generation: Cognitive Performance in the Framingham Offspring Cohort
Experimental Aging Research, 2004, 30, 333-358
1.7141Citations (PDF)
500Stroke risk profile, brain volume, and cognitive function
Neurology, 2004, 63, 1591-1599
1.0229Citations (PDF)
501Dementia After Stroke
Stroke, 2004, 35, 1264-1268
5.9349Citations (PDF)
502Stroke Risk Profile Predicts White Matter Hyperintensity Volume
Stroke, 2004, 35, 1857-1861
5.9457Citations (PDF)
503Homocysteine and the brain: vascular risk factor or neurotoxin?17.924Citations (PDF)
504Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease8.1264Citations (PDF)
505Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men16.51,187Citations (PDF)
506Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease34.53,152Citations (PDF)
507Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease6.8134Citations (PDF)
508Bone Mineral Density and Verbal Memory Impairment: Third National Health and Nutrition Examination Survey3.322Citations (PDF)
509Elevated Midlife Blood Pressure Increases Stroke Risk in Elderly Persons8.183Citations (PDF)
510Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro
Statistics in Medicine, 2000, 19, 1495-1522
1.7169Citations (PDF)
511Statins and the risk of dementia
Lancet, The, 2000, 356, 1627-1631
62.11,725Citations (PDF)
512Lifetime risk of dementia and Alzheimer's disease
Neurology, 1997, 49, 1498-1504
1.0468Citations (PDF)
513Apolipoprotein E ε4 Allele and the Lifetime Risk of Alzheimer's Disease
Archives of Neurology, 1995, 52, 1074
6.8165Citations (PDF)
514Reply Effect yes, role no!2.21Citations (PDF)
515Atrial natriuretic peptide: an atavistic hormone?2.23Citations (PDF)
516Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study0.1289Citations (PDF)
517Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis0.1252Citations (PDF)
518Short Sleep Duration and Hypertension: A Double Hit for the Brain4.06Citations (PDF)
519Circulating Endocannabinoids and Cognitive Function in Older Adults
0, ,
1Citations (PDF)
520Cardiovascular disease and bipolar disorder: A review of pathophysiology and treatment implications1.22Citations (PDF)
521Self-Reported Hearing Aid Use and Risk of Incident Dementia
JAMA Neurology, 0, 82, 1195
17.66Citations (PDF)
522Signature White Matter Hyperintensity Locations Associated With Vascular Risk Factors Derived From 15 653 Individuals
Stroke, 0, 56, 3047-3059
5.94Citations (PDF)
523A steep decline in diastolic blood pressure over early to mid-life is associated with tau-PET burden in dementia-free adults2.61Citations (PDF)
524Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study
Neurology, 0, 105,
1.07Citations (PDF)
525MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics
Annals of Neurology, 0, 99, 449-458
6.64Citations (PDF)
526Empowering community health workers in dementia care in South Texas2.61Citations (PDF)
527The 25-Year Incidence and Progression of Hearing Loss in the Framingham Offspring Study
JAMA Network Open, 0, 8, e2539371
6.62Citations (PDF)
528Association of Platelet Aggregation With Markers of Alzheimer Disease Pathology in Middle-Aged Participants of the Framingham Heart Study
Neurology, 0, 105,
1.02Citations (PDF)
529Higher Burden of Cerebral Small Vessel Disease Is Associated With Risk of Incident Stroke in Community‐Dwelling Individuals4.03Citations (PDF)
530Spatial Dissociation of Atrophy and Hypophysiology in Alzheimer's Disease: Implications for Biomarkers3.50Citations (PDF)
531Circulating Markers of Inflammation and Endothelial Dysfunction Associated With Increased Progression of Internal Carotid Intima‐Media Thickness in the Population‐Based Framingham Heart Study4.00Citations (PDF)
532Unsupervised quality assessment with generative adversarial networks for 3D OCTA microvascular imaging2.80Citations (PDF)
533Environment‐susceptible genetic loci for imaging‐based preclinical markers of ADRD, and the influence of modifiable risk factors0.50Citations (PDF)
534Multi‐omics integration highlights transposable elements as latent regulatory factors involved in the preclinical processes of Alzheimer's disease and related dementias‐ADRD0.50Citations (PDF)
535Gut Microbiome Diversity as a Mediator Between Life's Essential 8 Adherence and Cognitive Function0.50Citations (PDF)
536Sleep health influencing gut microbiome showed an association with cognitive performance0.50Citations (PDF)
537Associations of Left Atrial Dimension and Ventricular Mass With Long-Term Health Outcomes
JACC: Advances, 0, 5, 102643
1.30Citations (PDF)
538Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults
0, 2,
0Citations (PDF)
539Modeling small vessel disease burden and vascular dementia likelihood from NACC data0.50Citations (PDF)
540Association Between Nerve Growth Factor and Clinical Stroke and Covert Brain Infarcts: The FHS4.00Citations (PDF)
541Detecting Cognitive Impairment Early in Hispanic and Black Older Adults1.30Citations (PDF)